-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pfev8UfAP45mfAWDKDX2O3Ihkzhwj/EDDauvSu5teLf2yr8SBHaAWL0lTruUa5P5 TcP1oUBtqtX8d3u379Nhog== 0001104659-05-016655.txt : 20050415 0001104659-05-016655.hdr.sgml : 20050415 20050415150305 ACCESSION NUMBER: 0001104659-05-016655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050413 FILED AS OF DATE: 20050415 DATE AS OF CHANGE: 20050415 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173490200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pauwels Eric CENTRAL INDEX KEY: 0001323212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21481 FILM NUMBER: 05753456 BUSINESS ADDRESS: BUSINESS PHONE: (617) 349-0200 MAIL ADDRESS: STREET 1: C/O TKTX, 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0202 4 2005-04-13 0 0000885259 TRANSKARYOTIC THERAPIES INC TKTX 0001323212 Pauwels Eric 700 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Sr. VP - Global Commercial Ops Stock Option (right to buy) 27.74 2005-04-13 4 A 0 100000 0 A 2015-04-13 Common Stock 100000 100000 D The option becomes exercisable in five equal annual installments beginning on April 13, 2006. /s/ Philip T. Chase, Attorney-in-Fact 2005-04-15 -----END PRIVACY-ENHANCED MESSAGE-----